Industry

Reflects QuidelOrtho’s confidence in its strong balance sheet and cash generation QuidelOrtho continues to prioritize investments in R&D, manufacturing capacity, and debt paydown SAN DIEGO–(BUSINESS WIRE)–QuidelOrtho Corporation (NASDAQ: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that its board of directors … [Read more…]

MENLO PARK, Calif.–(BUSINESS WIRE)–Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, announced today it has filed an amended complaint against Foresight Diagnostics. The amended complaint asserts a newly-issued patent in Personalis’ growing intellectual property portfolio relating to detection of molecular residual disease (MRD). The patent, US Patent No. 11,408,033 (the “‘033 patent”), … [Read more…]

MISSISSAUGA, Ontario & PHOENIX–(BUSINESS WIRE)–MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), a technology-enabled retail pharmacy company, today announced that the company will present at the upcoming Inaugural Gilmartin Group Emerging Growth Company Showcase, taking place virtually. Members of management are scheduled to present on Wednesday, August 31, 2022 at 1:20 p.m. ET. Interested parties can access … [Read more…]

GERMANTOWN, Md.–(BUSINESS WIRE)–Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to present at the upcoming Inaugural Gilmartin Group Emerging Showcase, taking place virtually. Management is scheduled to present on Wednesday, August 31, … [Read more…]

Hosting Call on Wednesday, August 24th at 5 pm ET TORONTO & DALLAS–(BUSINESS WIRE)–Perimeter Medical Imaging AI, Inc. (TSX-V:PINK)(OTC:PYNKF) (FSE:4PC) (“Perimeter” or the “Company”) – a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address high unmet medical needs – today announced it will report its second quarter … [Read more…]

OXFORD, England–(BUSINESS WIRE)–Exscientia plc (Nasdaq: EXAI) Recent developments in the Company’s pipeline, collaborations, and operations, as well as financial results for the second quarter and first half 2022, are summarised below. In addition, Exscientia will host a conference call Thursday, August 18 at 1:30 p.m. BST / 8:30 a.m. ET to provide an overview of … [Read more…]

Federal initiative aggressively expands domestic production of vital research tool to meet current and future capacity demands TAUNTON, Mass.–(BUSINESS WIRE)–#3Acertification–Harpak-ULMA, the industry leader in smart, connected packaging solutions, has been selected by a major medical device producer to provide automated flow wrap packaging lines for pipette tip production. The move will ensure reliable, US-based production … [Read more…]

MedWand™ Solutions Receives FDA 510(k) Clearance Evaluation Kit, Mobile Clinic, & Remote Clinics Available for Health Professionals TODAY RANCHO SANTA MARGARITA, Calif. & LAS VEGAS–(BUSINESS WIRE)–MedWand Solutions, Inc. is pleased to announce that the company’s groundbreaking MedWand device and VirtualCare ecosystem is commercially available to enable clinical exams with its comprehensive care solutions. Poised to … [Read more…]

Price of ZYNTEGLO reflects potentially curative clinical benefit through achievement of durable transfusion independence and normal or near normal total hemoglobin levels Innovative outcomes-based contract offering includes single upfront payment and up to 80% risk-sharing ZYNTEGLO will be available through a network of Qualified Treatment Centers with experience delivering novel cell and gene therapies “my … [Read more…]

ZYNTEGLO offers potentially curative benefit across ages and genotypes, through the achievement of durable transfusion independence and normal or near normal total hemoglobin levels Management team to host conference call Thursday, August 18 at 8:00 am ET SOMERVILLE, Mass.–(BUSINESS WIRE)–bluebird bio, Inc. (Nasdaq: BLUE) today announced the U.S. Food and Drug Administration (FDA) has approved … [Read more…]